Trial Details
Not RecruitingBasic Information
| Clinical ID | c3299 |
|---|---|
| Identifier | EUCTR2008-008285-12-IT |
| Trial Title | PROSPECTIVE STUDY ?IBDISC?: Regeneration and Immunity in patients affected by IBD undergoing immunomodulatory treatment and adjuvant role of G-CSF and/or plasmapheresis (Inflammatory Bowel Diseases Immunity and Stem Cells) - IBDISC |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory bowel disease MedDRA version: 9.1_Level: PT_Classification code 10011401_ MedDRA version: 9.1_Level: LLTClassification code 10045282 |
| Interventions | Trade Name: GRANOCYTE 34 Pharmaceutical Form: Solution for injection INN or Proposed INN: Lenograstim Concentration unit: g/kg microgram(s)/kilogram Concentration type: equal Concentration number: 10- |
Participant Information
| Sponsor | POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI |
|---|---|
| City | - |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |